Skip to content
Search

Latest Stories

CCA's analysis shows net loss of 670 community pharmacies in England

The Company Chemists’ Association (CCA)’s analysis on permanent closures of community pharmacies in England showed that there has been a net loss of 670 pharmacies between 2015 and 2022.

The analysis highlighted that 37 per cent of permanent closures of pharmacies and GP practices have occurred in the 20 per cent most deprived parts of England.


Current trends indicate that primary care ‘cold spots’ could soon emerge – areas where there is significantly reduced or inadequate access to a pharmacy or a GP.

The CCA’s analysis shows that some of the most deprived neighborhoods concentrated in the North West, the West Midlands and Yorkshire have faced the highest losses of local pharmacies and GP practices since 2015.

It demonstrates that the trend of permanent closures amongst pharmacies and GP practices is worsening. Moreover, this burden is likely to be felt unevenly with permanent closures occurring disproportionately in areas of high deprivation. Without action, deprived communities, where need is typically greater, may no longer be able to access the GP and pharmacy services they require.

Malcolm Harrison, Chief Executive of the CCA said: “The Government is sleepwalking into a disaster within primary care, and we could soon see primary care cold spots emerge in different parts of England. Unfortunately, the communities with the greatest need could see access to primary care services diminish the most which will only worsen health inequalities.

"The CCA has been warning about permanent closures of pharmacies for some time. The sector is underfunded by more than £67,000 per pharmacy annually, money which could be invested in frontline staff to provide patient care. This is a wake-up call to the Government – primary care desperately needs investment.

We’re calling for a fully-funded Pharmacy First scheme to bring investment into the sector and to ensure patients with minor ailments can be seen by their pharmacist first – freeing up GP time to see those patients who absolutely need to see their GP”.

Taiwo Owatemi MP, the Chair of the All-Party Parliamentary Group on Pharmacy said: “The community pharmacy sector is critically underfunded and only by long term investment over an extended period of time will we begin to see an end to the mass departure of pharmacy staff to other sectors across the primary care network. The CCA’s research makes clear that the situation is dire with nearly 700 pharmacies closing their doors for good between 2015 and 2022. There simply can be no more delays. People across the country are already missing out on crucial healthcare support – this underutilized sector must be given the support it needs.

Too frequently we view our pharmacies as just being the shop where we pick up our medicines. Pharmacies can and must be commissioned to do so much more. In Wales and Scotland, Pharmacy First schemes are already in place so that urgent care can be provided inside pharmacies, within communities where people live. England must follow.

Pharmacies should be the first port of call for any minor illnesses. Pharmacists have the skills already; they just want the opportunity to put them into practice. Yet, this can only happen if the Government is prepared to step up to the plate and make those long-term commitments to the sector that will keep it alive for future generations.”

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less